At Demax, we focus on the R&D and production of disposable interventional therapy products for the cardiovascular system. Demax Group was established in 2004 and headquartered in Australia. It consists of Demax Medical Australia, Beijing Demax Medical, and Tianjin Demax Medical.
In the past 17 years of development, Demax has always adhered to the core value of "Quality for Life." We are putting product quality in the first place, which significantly winning the trust and support from more and more customers. In China, on average, about 3 out of 10 have enjoyed the services provided by Demx among the 300 million cardiovascular patients.
Until now, Demax has established long-term collaboration relations with customers and medical institutions from more than 70 countries; our products are distributing worldwide.
Demax people adhere to the "Technology-based, Technology-first" philosophy and always insist on mastering core technologies independently. Through continuous investment in research and development, Demax has obtained more than 70 patents，matured hydrophilic coating preparation and coating technology, balloon molding technology, catheter welding technology, and the like.
Through tireless efforts, Demax has successively obtained the approval and protection of Madrid International Registration of Marks from 2011 to 2014 in 9 countries, including South Korea, the United States, Turkey, Switzerland, Syria, Australia, the European Union, Iran, and Egypt. Besides, 12 products have obtained EU CE certification and ARTG certification, 1 product has received FDA 510K certification. In addition, all products on sale have obtained CFDA product registration certificate and production license, ISO9001 certificate, and ISO13485 certificate.

Demax Medical

Org chart

Teams

Offices